Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder

We examined the potential risks and benefits of switching from olanzapine to quetiapine in mentally stable, obese, or overweight patients with schizophrenia or schizoaffective disorder. Patients receiving olanzapine were randomized to continuing olanzapine treatment (N =68; 7.5–20 mg/day) or switchi...

Descripción completa

Detalles Bibliográficos
Autores principales: Deberdt, Walter, Lipkovich, Ilya, Heinloth, Alexandra N, Liu, Lin, Kollack-Walker, Sara, Edwards, Sara E, Hoffmann, Vicki Poole, Hardy, Thomas A
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621385/
https://www.ncbi.nlm.nih.gov/pubmed/19209252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621385/
https://www.ncbi.nlm.nih.gov/pubmed/19209252

Ejemplares similares